Primary record
3-[(2-Aminoethyl)thio]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid (4-nitrophenyl)methylester monohydrochloride compd. with 1-methyl-2-pyrrolidinone (1:1)
- 库存
- 2,982 克
- 纯度
- 99.2 %
- CAS
- 64221-86-9
化合物标识与属性
- CAS
- 64221-86-9
- PubChem CID
- 104838
- SMILES
- C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O
- Canonical SMILES
- C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCCN=CN)C[C@H]12
名称与同义词
- imipenem
- Imipemide
- Tienamycin
- Imipenem anhydrous
- N-Formimidoylthienamycin
- Imipenemum
- Imipenen
- 64221-86-9
- Primaxin
- Imipenem hydrate
- imipen
- Zienam
- Anhydrous Imipenem
- Imipenem (INN)
- Imipenem [INN]
- Imipenem monohydrate
- Imipenem CRS
- Imipenem, Anhydrous
- Imipenemum [Latin]
- N-formimidoyl thienamycin
- Imipenem-1-wasser
- Primaxin (TN)
- Anhydrous, Imipenem
- Prestwick_844
- Imipenem intermediate
- IMIPEM
- Imipenem (anhydrous)
- Imipenem & clavulanate
- N Formimidoylthienamycin
- CHEMBL148
- IMIPENEM [MI]
- IMIPENEM ANHYDRATE
- N-formimidoylthien-amycin
- AC1L2XLB
- Prestwick0_000519
- Prestwick1_000519
- Prestwick2_000519
- Prestwick3_000519
- RefChem:790833
- CHEBI:471744
- Q20IM7HE75
- UNII-Q20IM7HE75
- DTXSID2023143
- D0H3TD
- Epitope ID:120384
- IMIPENEM [WHO-DD]
- UNII-71OTZ9ZE0A
- Imipenem, N-Formimidoyl thienamycin
- Imipenem monohydrate (h2o)
- DTXCID903143
- 71OTZ9ZE0A
- MK 0787
- MK-0787
- BSPBio_000477
- C12H17N3O4S
- cc-394
- BIDD:GT0686
- Imipenem and cilastatin sodium
- SPBio_002398
- ZSKVGTPCRGIANV-ZXFLCMHBSA-N
- BPBio1_000525
- orb1992144
- SCHEMBL1649260
- SCHEMBL2231086
- SCHEMBL8781920
- C12H17N3O4S.H2O
- C12H19N3O5S
- EINECS 264-734-5
- GTPL10821
- HY-B1369A
- Imipenem [USAN:BAN:INN:JAN]
- Imipenem [USAN:INN:BAN:JAN]
- Primaxin (imipenem + cilastatin)
- MFCD00864955
- MK-787
- MK0787
- HMS1569H19
- HMS2090A15
- HMS2096H19
- HMS3260H20
- HMS3713H19
- KST-1A7214
- Pharmakon1600-01506001
- NSC-759901
- RECARBRIO COMPONENT IMIPENEM
- BCP13012
- ZINC4097225
- Tox21_110689
- Tox21_500279
- AC-528
- AR-1A6479
- BDBM50049708
- BDBM50213266
- C12-H17-N3-O4-S
- CID104838
- EBC-26520
- MSK162950
- NSC717864
- NSC759901
- Imipenem [USAN:USP:INN:BAN:JAN]
- AKOS016010844
- Tox21_110689_1
- AN-9651
- CCG-220519
- CCG-221583
- DB01598
- LP00279
- NSC-717864
- SDCCGSBI-0633697.P001
- (5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- 3-(2-Naphthyl)-L-alanine Hydrochloride
- NCGC00016928-01
- NCGC00167958-01
- NCGC00167958-02
- NCGC00167958-03
- NCGC00167958-05
- NCGC00167958-09
- NCGC00260964-01
- AJ-47996
- AN-15734
- AS-75130
- BC209124
- C12-H17-N3-O4-S.H2-O
- J32.525B
- 74431-23-5
- CAS-64221-86-9
- CS-0077844
- Ethyl alpha-methyl-beta-oxopyrazinepropionate
- NS00005888
- (5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure
- C06665
- D04515
- D96091
- X-2302
- (5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
- AB01563339_01
- Recarbrio (imipenem + cilastatin + relebactam).
- 847I667
- A834678
- EN300-19766283
- Q425152
- SR-05000000294
- 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-,(5R,6S)-
- 442847-66-7
- SR-05000000294-2
- SR-05000000294-5
- BRD-K23200955-002-01-5
- BRD-K23200955-002-02-3
- p-Nitrobenzyl -2- -6-( carbapen-2-em-3-carboxylate
- (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- (5R,6S)-6-[(1R)-1-hydroxyethyl]-3-[(2-methanimidamidoethyl)sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- 6623-14-9
- IMP
- Benzenamine,4-(2-methylbutyl)-N-[[4-(octyloxy)phenyl]methylene]
- (5R,6S)-3-((2-formimidamidoethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- (5R,6S)-3-[2-(aminomethyleneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- (5R,6S)-6-[(1R)-1-hydroxyethyl]-3-({2-[(iminomethyl)amino]ethyl}thio)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- IPM
- Thienamycin p-nitrobenzylester hydrochloride (N-methylpyrrolidinonesolvate)
- Thienamycin p-nitrobenzylester hydrochloride(N-methylpyrrolidinonesolvate)
- (5R)-6beta-[(R)-1-Hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- (5R,5beta)-6beta-[(R)-1-Hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- (5R,6S)-3-((2-((E)-(aminomethylidene)amino)ethyl)sulfanyl)-6-((1R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
- (5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid monohydrate
- (5R,6S)-3-({2-[(E)-(aminomethylidene)amino]ethyl}sulfanyl)-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- (5R,6S)-3-(2-(aminomethylideneamino)ethylsulfanyl)-6-((1R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
- (5R,6S)-3-(2-(aminomethylideneazaniumyl)ethylsulfanyl)-6-((1R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylate
- (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo(3.2.0)hept-2-ene-2-carboxylic acid
- (5R,6S)-3-[2-(Iminomethylamino)ethylthio]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hepta-2-ene-2-carboxylic acid
- (5R,6S)-6-(1R)-1-hydroxyethyl-3-(2-methanimidamidoethyl)sulfanyl-7-oxo-1-azabicyclo3.2.0hept-2-ene-2-carboxylic acid
- (5R,6S)-6-[(1R)-1-hydroxyethyl]-3-({2-[(iminomethyl)amino]ethyl}sulfanyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- (5R,6S)-6-[(1R)-1-hydroxyethyl]-3-(2-methanimidamidoethylsulfanyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- [5R-[5.alpha.,6.alpha.(R*)]]-6-(1-Hydroxyethyl)-3-[[2- [(iminomethyl)amino]ethyl]thio]-7-oxo-1-azabicyclo[3.2.0]hept-2- ene-2-carboxylic acid monohydrate
- [5R-[5.alpha.,6.alpha.(R*)]]-6-(1-Hydroxyethyl)-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid monohydrate
- 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-((1R)-1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R,6S)-
- 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R-(5-alpha,6-alpha(R*)))-
- 1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID, 6-(1-HYDROXYETHYL)-3-((2-((IMINOMETHYL)AMINO)ETHYL)THIO)-7-OXO-, (5R-(5.ALPHA.,6.ALPHA.(R*)))-
- 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R-(5alpha,6alpha(R*)))-
- 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, monohydrate, (5R-(5alpha,6alpha(R*)))-
- 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-, (5R,6S)-
- 103730-39-8
- 264-734-5
- 3-[(2-Aminoethyl)thio]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid (4-nitrophenyl)methylester monohydrochloride compd. with 1-methyl-2-pyrrolidinone (1:1)
- 85960-17-4